Paragon Capital Management LTD Amgen Inc Transaction History

Paragon Capital Management LTD

$531 Million
Q2 2024

A detailed history of Paragon Capital Management LTD transactions in Amgen Inc stock. As of the latest transaction made, Paragon Capital Management LTD holds 2,820 shares of AMGN stock, worth $903,979. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,820

Previous 2,820 -0.0%

Holding current value

$903,979

Previous $801,000 9.99%

% of portfolio

0.17%

Previous 0.14%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$268.87 - $324.56 $14,250 - $17,201	-53 Reduced 1.84%	2,820 $801,000
Q4 2023 Jan 12, 2024	BUY	$255.7 - $288.46 $13,552 - $15,288	53 Added 1.88%	2,873 $827,000
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $324,570 - $386,505	-1,500 Reduced 34.72%	2,820 $648,000
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $854,539 - $1.05 Million	4,320 New	4,320 $1.02 Million
Q1 2020 Apr 29, 2020	SELL	$182.24 - $241.7 $771,786 - $1.02 Million	-4,235 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$174.11 - $208.62 $17,062 - $20,444	-98 Reduced 2.26%	4,235 $820,000
Q2 2019 Jul 23, 2019	BUY	$166.7 - $195.41 $1,000 - $1,172	6 Added 0.14%	4,333 $798,000
Q1 2019 May 01, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.02%	4,327 $822,000
Q4 2018 Jan 29, 2019	SELL	$178.4 - $208.25 $1,962 - $2,290	-11 Reduced 0.25%	4,326 $842,000
Q3 2018 Nov 05, 2018	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.05%	4,337 $899,000
Q2 2018 Aug 21, 2018	SELL	$166.05 - $186.51 $498 - $559	-3 Reduced 0.07%	4,335 $800,000
Q4 2017 Jan 29, 2018	BUY	$168.79 - $188.59 $168 - $188	1 Added 0.02%	4,338 $754,000
Q3 2017 Oct 26, 2017	BUY	$167.29 - $191.0 $725,536 - $828,367	4,337	4,337 $809,000

Others Institutions Holding AMGN

# of Institutions

3,052

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Capital Management LTD with notifications on news.

Account

Paragon Capital Management LTD Amgen Inc Transaction History